EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.567
March 31, 2026 -1.565
December 31, 2025 -1.613
September 30, 2025 -1.751
June 30, 2025 -1.949
March 31, 2025 -2.232
December 31, 2024 -2.399
September 30, 2024 -2.614
June 30, 2024 -2.523
March 31, 2024 -2.639
December 31, 2023 -2.793
September 30, 2023 -2.682
June 30, 2023 -2.903
March 31, 2023 -2.801
December 31, 2022 -2.597
Date Value
September 30, 2022 -2.662
June 30, 2022 -2.560
March 31, 2022 -3.956
December 31, 2021 -3.851
September 30, 2021 -2.835
June 30, 2021 -4.560
March 31, 2021 -2.754
December 31, 2020 -2.563
September 30, 2020 -3.222
June 30, 2020 -1.059
March 31, 2020 -0.9568
December 31, 2019 -0.8377
September 30, 2019 -0.5716
June 30, 2019 -0.3527
March 31, 2019 -0.1578

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Insmed, Inc. -4.105
United Therapeutics Corp. 27.96
AbbVie, Inc. 3.537
TG Therapeutics, Inc. 2.746
Travere Therapeutics, Inc. -0.7636